25 Aug Boston Biodevelopment
Founded in 2009, Boston Biodevelopment is a premium regulatory strategy consulting firm led by highly experienced regulatory professionals—including former Heads of Regulatory Affairs—who provide world-class, hands-on leadership, and management throughout the development and approval of new therapies. As a signature service, we offer Interim Head of Regulatory Affairs Leadership, delivering seasoned executive leadership that ensures strategic continuity and regulatory confidence during times of transition or growth. Boston Biodevelopment has deep expertise in regulatory affairs across a wide range of therapeutic areas and rare disease in all modalities in biopharma. Our consultants excel at guiding the regulatory development of biologics, small molecules, cell and gene therapies, and gene editing products through the entire product lifecycle. Our clients turn to us when they need immediately effective regulatory professionals seamlessly embedded within their teams to advance development programs and bring the promise of life sciences to patients.
